RSV

RSV Prophylaxis for Infants and Children: Now Available, But Is it Accessible?

Leave a Comment / NURSING JOBS / By

Add To Favorites July, a month typically characterized by the relative hibernation of communicable respiratory illnesses, brought with it the U.S. Food and Drug Administration’s (FDA’s) approval of nirsevimab-alip (brand name: Beyfortus) and thus a reminder of the gearing up necessary for the respiratory disease season ahead. Nirsevimab, approved for the prevention of respiratory syncytial …

RSV Prophylaxis for Infants and Children: Now Available, But Is it Accessible? Read More »

GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites London: GSK does not expect initial uptake of its RSV vaccine will be as swift as it was for its blockbuster shingles vaccine, though the company is confident in its new inoculation, Chief Executive Emma Walmsley said on Wednesday. The company will launch the vaccine against respiratory syncytial virus (RSV) in the …

GSK expects RSV vaccine uptake will be slower than shingles vaccine-CEO, ET HealthWorld Read More »

UK health regulator approves GSK’s vaccine for common respiratory virus RSV, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: Britain’s health regulator approved GSK’s vaccine for the respiratory syncytial virus (RSV), which causes thousands of hospitalisations and deaths annually, the drugmaker said on Monday. The Medicines and Healthcare products Regulatory Agency (MHRA) authorised GSK’s shot, called Arexvy, for active immunisation to prevent lower respiratory tract disease caused by RSV in …

UK health regulator approves GSK’s vaccine for common respiratory virus RSV, ET HealthWorld Read More »

GSK’s RSV vaccine shows long-term efficacy in late-stage trial, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites New Delhi: GSK on Wednesday said its vaccine for the respiratory syncytial virus (RSV), which recently won EU approval, showed strong long-term protection in older adults in a late-stage trial. The British drugmaker said a ‘Phase III’ trial showed vaccine efficacy against RSV-lower respiratory tract disease and severe disease over two full …

GSK’s RSV vaccine shows long-term efficacy in late-stage trial, ET HealthWorld Read More »

Sanofi and AstraZeneca’s preventive RSV therapy appears safe: FDA staff, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: The U.S. Food and Drug Administration’s staff reviewers said on Tuesday Sanofi and partner AstraZeneca’s experimental therapy to prevent respiratory syncytial virus (RSV) infections in infants appeared safe and effective. The RSV prevention antibody, nirsevimab, showed an overall favorable safety profile in clinical trials, the FDA staff said in documents published …

Sanofi and AstraZeneca’s preventive RSV therapy appears safe: FDA staff, ET HealthWorld Read More »

US FDA approves Pfizer’s RSV vaccine, Health News, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites Bengaluru: The US Food and Drug Administration on Wednesday approved Pfizer Inc‘s respiratory syncytial virus (RSV) vaccine for older adults, making it the second shot against the common respiratory disease that can be fatal for seniors. The approval comes less than a month after the FDA approved a similar shot by rival …

US FDA approves Pfizer’s RSV vaccine, Health News, ET HealthWorld Read More »

GSK’s RSV vaccine first to get EU regulator’s nod, ET HealthWorld

Leave a Comment / Medico News India / By

Add To Favorites New Delhi: The European Medicines Agency (EMA) on Wednesday recommended authorization of GSK’s Arexvy vaccine for respiratory syncytial virus (RSV) in adults aged 60 and older, putting Europe on track to approve the world’s first such vaccine. The recommendation puts GSK ahead of rival Pfizer Inc in the race to tap into …

GSK’s RSV vaccine first to get EU regulator’s nod, ET HealthWorld Read More »


Wallet

Community

Home

Favourites

Messages

New Report

Close

×